Morning Overview on MSN
How science and luck sparked a radical new era in schizophrenia treatment
The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a ...
The FDA is reportedly considering broadening the types of drugs that can be sold without a prescription, a move some pharmacy experts say could raise safety risks ...
Morning Overview on MSN
NIH is testing a controversial COVID drug as a surprise cancer therapy
A non-NIH clinical trial is now testing ivermectin, the antiparasitic drug that became a lightning rod during the COVID-19 pandemic, as a potential weapon against one of the most aggressive forms of ...
When Terra Field started taking Wegovy for weight loss in 2022, she finally understood what satiety truly felt like. “It felt the way I thought my body should have been operating the entire time,” ...
Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and ...
In the field of neuropharmacology, the search for the next medical breakthrough often feels like a high-stakes gamble. For decades, the pharmaceutical industry has struggled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results